Login / Signup
Renzhong Lu
(Ke-He Ruan)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 6
Top Topics
Pulmonary Arterial Hypertension
Cell Wall
Nitric Oxide Synthase
Drug Discovery
Top Venues
Future medicinal chemistry
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Renzhong Lu
,
Hironori Akasaka
Design, synthesis and characterization of lead compounds as anti-inflammatory drugs targeting mPGES-1 via enzymelink screening.
Future medicinal chemistry
(2023)
Renzhong Lu
Latest advancements in the study of the relationship between NSAIDs and three prostaglandin E2 synthases.
Future medicinal chemistry
(2023)
Krista LaBorde
,
Renzhong Lu
,
Ke-He Ruan
Latest progress in the development of cyclooxygenase-2 pathway inhibitors targeting microsomal prostaglandin E 2 synthase-1.
Future medicinal chemistry
14 (6) (2022)
Diana T Ruan
,
Renzhong Lu
,
Ke-He Ruan
Redirecting thromboxane A2 and prostacyclin biosyntheses from thrombotic to antithrombotic property by an Enzymelink.
Future medicinal chemistry
13 (9) (2021)
Diana T Ruan
,
Nanhong Tang
,
Hironari Akasaka
,
Renzhong Lu
,
Ke-He Ruan
Engineering 'Enzymelink' for screening lead compounds to inhibit mPGES-1 while maintaining prostacyclin synthase activity.
Future medicinal chemistry
13 (13) (2021)
Karishma Thakkar
,
Cheng-Huai Ruan
,
Renzhong Lu
Recent advances of cannabidiol studies in medicinal chemistry, pharmacology and therapeutics.
Future medicinal chemistry
13 (22) (2021)